177 related articles for article (PubMed ID: 15837405)
61. Epinephrine-infused CTHA for HCCs.
Tanaka O; Yamagami T; Kato T; Iida S; Hirota T; Nishimura T
Abdom Imaging; 2008; 33(3):308-12. PubMed ID: 17431712
[TBL] [Abstract][Full Text] [Related]
62. [Imaging diagnosis of hepatocellular carcinomas].
Matsui O; Kadoya M; Kameyama T; Yoshikawa J; Arai K; Gabata T; Takashima T; Ida M; Miyata S
Gan To Kagaku Ryoho; 1989 Jan; 16(1):25-33. PubMed ID: 2536268
[TBL] [Abstract][Full Text] [Related]
63. Progression to hypervascular hepatocellular carcinoma: correlation with intranodular blood supply evaluated with CT during intraarterial injection of contrast material.
Hayashi M; Matsui O; Ueda K; Kawamori Y; Gabata T; Kadoya M
Radiology; 2002 Oct; 225(1):143-9. PubMed ID: 12354998
[TBL] [Abstract][Full Text] [Related]
64. Detection of small hypervascular hepatocellular carcinomas in cirrhotic patients: comparison of superparamagnetic iron oxide-enhanced MR imaging with dual-phase spiral CT.
Lee JM; Kim IH; Kwak HS; Youk JH; Han YM; Kim CS
Korean J Radiol; 2003; 4(1):1-8. PubMed ID: 12679628
[TBL] [Abstract][Full Text] [Related]
65. Evaluation of optimal timing of arterial phase imaging for the detection of hypervascular hepatocellular carcinoma by using triple arterial phase imaging with multidetector-row helical computed tomography.
Murakami T; Kim T; Kawata S; Kanematsu M; Federle MP; Hori M; Okada A; Kumano S; Sugihara E; Tomoda K; Nakamura H
Invest Radiol; 2003 Aug; 38(8):497-503. PubMed ID: 12874516
[TBL] [Abstract][Full Text] [Related]
66. Hepatic falciform ligament artery in patients with chronic liver diseases: detection on computed tomography hepatic arteriography.
Tajima T; Yoshimitsu K; Irie H; Nishie A; Hirakawa M; Ishigami K; Ushijima Y; Okamoto D; Honda H
Acta Radiol; 2009 Sep; 50(7):743-51. PubMed ID: 19533449
[TBL] [Abstract][Full Text] [Related]
67. Recommended iodine dose for multiphasic contrast-enhanced mutidetector-row computed tomography imaging of liver for assessing hypervascular hepatocellular carcinoma: multicenter prospective study in 77 general hospitals in Japan.
Ichikawa T; Okada M; Kondo H; Sou H; Murakami T; Kanematsu M; Yoshikawa S; Shiosakai K; Hayakawa A; Awai K; Yoshimitsu K; Yamashita Y
Acad Radiol; 2013 Sep; 20(9):1130-6. PubMed ID: 23931427
[TBL] [Abstract][Full Text] [Related]
68. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.
Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Muhi A; Araki T
Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092
[TBL] [Abstract][Full Text] [Related]
69. Sensitivity of superselective arteriography for small hepatocellular carcinoma compared with proximal arteriography and computed tomography during superselective arteriography.
Takayasu K; Maeda T; Iwata R
Jpn J Clin Oncol; 2002 Jun; 32(6):191-5. PubMed ID: 12110634
[TBL] [Abstract][Full Text] [Related]
70. Detection of hepatocellular carcinoma: value of adding delayed phase imaging to dual-phase helical CT.
Lim JH; Choi D; Kim SH; Lee SJ; Lee WJ; Lim HK; Kim S
AJR Am J Roentgenol; 2002 Jul; 179(1):67-73. PubMed ID: 12076907
[TBL] [Abstract][Full Text] [Related]
71. Spectral CT imaging in the differential diagnosis of necrotic hepatocellular carcinoma and hepatic abscess.
Yu Y; Guo L; Hu C; Chen K
Clin Radiol; 2014 Dec; 69(12):e517-24. PubMed ID: 25248290
[TBL] [Abstract][Full Text] [Related]
72. Ferucarbotran-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma.
Kim SH; Choi D; Kim SH; Lim JH; Lee WJ; Kim MJ; Lim HK; Lee SJ
AJR Am J Roentgenol; 2005 Apr; 184(4):1069-76. PubMed ID: 15788575
[TBL] [Abstract][Full Text] [Related]
73. Preoperative detection of malignant hepatic tumors: comparison of combined methods of MR imaging with combined methods of CT.
Kondo H; Kanematsu M; Hoshi H; Murakami T; Kim T; Hori M; Matsuo M; Nakamura H
AJR Am J Roentgenol; 2000 Apr; 174(4):947-54. PubMed ID: 10749228
[TBL] [Abstract][Full Text] [Related]
74. Hepatocellular carcinoma in patients with chronic liver disease: comparison of SPIO-enhanced MR imaging and 16-detector row CT.
Kim YK; Kwak HS; Kim CS; Chung GH; Han YM; Lee JM
Radiology; 2006 Feb; 238(2):531-41. PubMed ID: 16371577
[TBL] [Abstract][Full Text] [Related]
75. Accessory left gastric artery from left hepatic artery shown on MDCT and conventional angiography: correlation with CT hepatic arteriography.
Ishigami K; Yoshimitsu K; Irie H; Tajima T; Asayama Y; Hirakawa M; Honda H
AJR Am J Roentgenol; 2006 Oct; 187(4):1002-9. PubMed ID: 16985149
[TBL] [Abstract][Full Text] [Related]
76. Clinical impact of low tube voltage computed tomography during hepatic arteriography with low iodine to detect hepatocellular carcinoma before transarterial chemoembolization.
Inoue A; Uemura R; Takaki K; Sonoda A; Ota S; Nitta N; Batsaikhan B; Takahashi H; Watanabe Y
Eur J Radiol; 2022 Sep; 154():110420. PubMed ID: 35809489
[TBL] [Abstract][Full Text] [Related]
77. "Reuse" study of low-tube-voltage CT arterial phase in the spoiled gadoxetic-acid liver MRI.
Ku MC; Lee CH; Park YS; Lee J; Choi JW; Kim KA; Park CM
Clin Imaging; 2015; 39(5):820-6. PubMed ID: 26159559
[TBL] [Abstract][Full Text] [Related]
78. Effect of injection rate of contrast material on CT of hepatocellular carcinoma.
Ichikawa T; Nakajima H; Nanbu A; Hori M; Araki T
AJR Am J Roentgenol; 2006 May; 186(5):1413-8. PubMed ID: 16632738
[TBL] [Abstract][Full Text] [Related]
79. Impact of multidetector CT hepatic arteriography on the planning of chemoembolization treatment of hepatocellular carcinoma.
Sze DY; Razavi MK; So SK; Jeffrey RB
AJR Am J Roentgenol; 2001 Dec; 177(6):1339-45. PubMed ID: 11717079
[TBL] [Abstract][Full Text] [Related]
80. CT perfusion of the liver during selective hepatic arteriography: pure arterial blood perfusion of liver tumor and parenchyma.
Komemushi A; Tanigawa N; Kojima H; Kariya S; Sawada S
Radiat Med; 2003; 21(6):246-51. PubMed ID: 14743897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
